NEW YORK (GenomeWeb News) — LabVantage said yesterday that it has licensed its Sapphire Laboratory Information Management Suite to an undisclosed “global biopharmaceutical company” that is in the cancer and immunological disease market.
Bridgewater, NJ-based LabVantage said the biopharma will use the technology to automate their research process and establish an enterprise-wide knowledgebase of research data.  
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.